Helga Pawelski, Uta Schnöckel, Dominik Kentrup, Alexander Grabner, Michael Schäfers, and Stefan Reuter
Research article (journal) | Peer reviewedMolecular imaging techniques such as single photon emission computed tomography (SPECT) or positron emission tomography are promising tools for noninvasive diagnosis of acute allograft rejection (AR). Given the importance of renal transplantation and the limitation of available donors, detailed analysis of factors that affect transplant survival is important. Episodes of acute allograft rejection are a negative prognostic factor for long-term graft survival. Invasive core needle biopsies are still the "goldstandard" in rejection diagnostics. Nevertheless, they are cumbersome to the patient and carry the risk of significant graft injury. Notably, they cannot be performed on patients taking anticoagulant drugs. Therefore, a noninvasive tool assessing the whole organ for specific and fast detection of acute allograft rejection is desirable. We herein review SPECT- and PET-based approaches for noninvasive molecular imaging-based diagnostics of acute transplant rejection.
Grabner, Alexander | Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D) |
Kentrup, Dominik Richard | Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D) |
Pawelski, Helga | Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D) |
Reuter, Stefan Johannes | Medical Clinic of Internal Medicine D (Nephrology and Rheumatology) (Med D) |
Schäfers, Michael | European Institute of Molecular Imaging (EIMI) |
Schnöckel, Uta | Clinic for Nuclear Medicine |